SOPHiA DDM™ Enhanced Clinical Exome Solution

A comprehensive solution combining a capture-based enrichment kit and the SOPHiA DDM™ platform for advanced clinical exome analysis, featuring targeted enhancements to increase coverage in critical regions and detect complex variants in a single workflow.

Detailed Description

Operating Principle

A genomic application integrating a capture enrichment kit with the advanced analytical modules of the SOPHiA DDM™ platform. The solution expands the SOPHiA DDM™ Clinical Exome Solution v3 kit with targeted probes to boost coverage in critical genomic regions and dedicated algorithms that reliably detect hard-to-identify variants, all within a single test.

SOPHiA Clinical Exome Solution

Clinical Applications

Specially designed to advance the study of rare and hereditary diseases, and to consolidate indications such as carrier screening and hereditary cancer into a unified workflow.

Benefits

Increases laboratory efficiency by consolidating multiple tests into one. Achieves sensitivities comparable to targeted panels in critical genomic regions. Reduces the complexity of genomic data interpretation with specific features through the use of dedicated software.

Intended Audience/User

Laboratories seeking an expanded clinical exome solution for multiple indications (rare/hereditary diseases, carrier screening, hereditary cancer) with advanced analytical capabilities and comprehensive support.

Key Features

Expanded coverage of the clinical exome + mitochondrial genome + ~200 relevant non-coding variants.
Specific enhancements for hereditary cancer (94 genes) and carrier screening (155 genes).
Reliable detection of complex variants: 1–2 exon CNVs, Alu insertions, gene conversions (PMS2/PMS2CL, SMN1/SMN2, CYP21A2), Boland inversions (MSH2), repetitive tracts (CFTR).
Proven analytical performance: SNV/Indel sensitivity 99.8%; precision 99.0%; >99% of on-target regions at >25×/>50× coverage.
Unified and efficient workflow with advanced interpretation tools: ACMG scoring, virtual panel generation, duo and trio analysis, and reporting.
Direct integration capabilities with Alamut™ Visual Plus.
Access to the SOPHiA Genetics community to securely and anonymously share knowledge among specialists.
Expert support and cloud storage: secure, unlimited storage following industrial encryption standards and restricted access control to empower the interpretation of challenging variants.

Area:

Exomes, Hereditary and/or Rare Diseases, Molecular Genetics
Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)